Alkermes (ALKS) shifts to fully integrated biopharma, leveraging Vibrance-2, Lybalvi growth, and Avadel buy to de-risk ...

Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutations KB407 transduction confirmed in all six patients with successful bronchoscopies irrespect ...

It sounds like Lilly did just that. The U.S. pharma announced on Wednesday that it was paying $14 per share of Ventyx—more ...

Company also announces renaming of Toliara Project to Vara Mada to better reflect the project's positive benefits to Madagascar and its global ...

Study is Evaluating Monthly Subcutaneous, Weekly Oral, and Daily Oral Regimens Designed to Explore Maintenance Dosing Regimens Following Initial Weight Loss with VK2735 ...

Biomed Industries to Advance NA-931 Into Two Global Phase 3 Trials as Monotherapy and in Combination With Semaglutide and Tirzepatide for Obesity Advancing NA-931 into two Phase 3 programs as ...

Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that dosing is complete in ...

Worker-owned cooperatives and direct-connect registries are reducing turnover and reshaping how older adults get care at home ...

At the end of an extended visit with an SEC school he prefers not to name, Tony Annese considered all that he had seen.

Worship service Sunday is at 10:30 a.m. led by Pastor James Woelmer. Sunday school and Bible study begin at 9:30 am. The ...

“Orforglipron and retatrutide from Eli Lilly exemplify the next generation of metabolic therapies: oral formulations that promise improved adherence, triple-hormone mechanisms that deliver superior ...

A multi-stakeholder group focused on strengthening dengue prevention and control policies in Asia[1] recently highlighted the ...